Open doors in the Dermatologies of 26 university-hospital centers for the third edition of ‘Dalla parte della tua pelle’, the national awareness campaign on atopic dermatitis promoted by Sidemast (Italian Society of Dermatology and Sexually Transmitted Diseases), with the support of ‘National Atopic Dermatitis Association (Andea) representing patients, created thanks to the non-conditioning contribution of Sanofi. From North to South Italy, free dermatological consultations will be available on 11, 18 and 25 March. Reservations are required on the dedicated toll-free number 800086875, active 7 days a week from 10 to 18.
The purpose of the campaign will be twofold, reads a note: to encourage patients to have a broader perception of the pathology, facilitating the diagnosis of atopic dermatitis; refer patients to reference centers throughout the country to undertake the most suitable treatment path for different needs. “Atopic dermatitis – explains Giuseppe Monfrecola, president of Sidemast – is a chronic inflammatory disease that presents with various skin manifestations, including redness extending to the limbs, trunk and face, accompanied by severe itching and burning and marked skin dryness. the disease is most visible are the face and neck, folds and hands.For this reason and for the constant itching sometimes associated with pain, atopic dermatitis has a very negative impact on the quality of life of patients, with repercussions in social relationships and in their school and work activities as the severe itching causes loss of sleep, with consequent relapses in study and work”.
“It is estimated that in Italy about 10% of adults and 20% of children suffer from atopic dermatitis – recalls Monfrecola – It often begins already in the first months of life, continuing then in childhood and adolescence, and being able to persist into The onset in adolescent-adult age and also in geriatric age is not excluded. In these cases the disease is often not recognized. With this initiative, Sidemast dermatologists set themselves the task of improving the diagnostic pathway of atopic dermatitis in adults, informing them about possible therapies in order to restore their peace of mind and the awareness that the disease can be kept under control thanks to the various treatments currently available”.